Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.84 - $16.79 $33,751 - $72,280
4,305 Added 34.75%
16,695 $139,000
Q1 2024

May 14, 2024

BUY
$13.2 - $17.76 $163,548 - $220,046
12,390 New
12,390 $220,000
Q3 2023

Nov 13, 2023

BUY
$6.02 - $7.76 $50,688 - $65,339
8,420 Added 45.51%
26,920 $191,000
Q2 2023

Aug 14, 2023

SELL
$5.79 - $9.11 $16,443 - $25,872
-2,840 Reduced 13.31%
18,500 $139,000
Q1 2023

May 12, 2023

BUY
$7.36 - $12.72 $157,062 - $271,444
21,340 New
21,340 $171,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.22B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.